The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Correlation of circulating tumor DNA (ctDNA) with clinical outcomes in appendiceal cancers (AC).
 
Vishesh Kothary
No Relationships to Disclose
 
Oliver Eng
Stock and Other Ownership Interests - Aileron Therapeutics; Alpine Immune Sciences; Iovance Biotherapeutics; Zymeworks
 
Blase N. Polite
Honoraria - American Journal of Managed Care; Genzyme; HMP; Physicans' Education Resource; Simon-Kucher and Partners
Consulting or Advisory Role - Cancer Expert Now
Speakers' Bureau - Natera
Travel, Accommodations, Expenses - Institute for Clinical and Economic Review; Tapestry Pharmaceuticals
 
Chih-Yi Liao
Consulting or Advisory Role - Exelixis; Incyte; Ipsen; Lexicon
Speakers' Bureau - Eisai; Exelixis
Research Funding - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Eisai; Exelixis; Incyte; Ipsen
 
Daniel V.T. Catenacci
Honoraria - Amgen; Archer; Astellas Pharma; Bristol-Myers Squibb; Daiichi Sankyo/UCB Japan; Five Prime Therapeutics; Foundation Medicine; Genentech/Roche; Gritstone Bio; Guardant Health; Lilly; Merck; Natera; Novartis; Pieris Pharmaceuticals; QED Therapeutics; Seagen; Taiho Pharmaceutical; Tempus; Zymeworks
Consulting or Advisory Role - Amgen; Astellas Pharma; Bristol-Myers Squibb; Daiichi Sankyo/UCB Japan; Genentech/Roche; Guardant Health; Lilly; Merck; Seagen; Taiho Pharmaceutical; Zymeworks
Speakers' Bureau - Daiichi Sankyo/Astra Zeneca; Genentech; Guardant Health; Lilly; Merck; Tempus
 
Ankit Dhiman
No Relationships to Disclose
 
Kiran Turaga
No Relationships to Disclose
 
Ardaman Shergill
Consulting or Advisory Role - Catalyst Pharmaceuticals; Triptych Health Partners
Research Funding - Daiichi Sankyo/Lilly (Inst); Hutchison MediPharma (Inst); InhibRx (Inst); Merck (Inst); Seattle Genetics/Astellas (Inst); TP Therapeutics (Inst); verastem (Inst)